[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ME01606B - Trans-4-[[(5s)-5-[[[3,5-bis(trifluormetil)fenil]metil](2-metil-2h-tetrazol-5-il)amino]-2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il]metil]cikloheksankarboksilna kiselina - Google Patents

Trans-4-[[(5s)-5-[[[3,5-bis(trifluormetil)fenil]metil](2-metil-2h-tetrazol-5-il)amino]-2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il]metil]cikloheksankarboksilna kiselina

Info

Publication number
ME01606B
ME01606B MEP-2013-114A MEP11413A ME01606B ME 01606 B ME01606 B ME 01606B ME P11413 A MEP11413 A ME P11413A ME 01606 B ME01606 B ME 01606B
Authority
ME
Montenegro
Prior art keywords
methyl
benzazepin
tetrazol
tetrahydro
trifluoromethyl
Prior art date
Application number
MEP-2013-114A
Other languages
English (en)
Inventor
Xinchao Chen
Scott Alan Frank
David Michael Remick
Steven Wayne Pedersen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42352717&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01606(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ME01606B publication Critical patent/ME01606B/me

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MEP-2013-114A 2009-06-30 2010-06-28 Trans-4-[[(5s)-5-[[[3,5-bis(trifluormetil)fenil]metil](2-metil-2h-tetrazol-5-il)amino]-2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il]metil]cikloheksankarboksilna kiselina ME01606B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22170809P 2009-06-30 2009-06-30
PCT/US2010/040125 WO2011002696A1 (en) 2009-06-30 2010-06-28 Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
EP10728558.7A EP2448933B1 (en) 2009-06-30 2010-06-28 Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid

Publications (1)

Publication Number Publication Date
ME01606B true ME01606B (me) 2014-09-20

Family

ID=42352717

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2013-114A ME01606B (me) 2009-06-30 2010-06-28 Trans-4-[[(5s)-5-[[[3,5-bis(trifluormetil)fenil]metil](2-metil-2h-tetrazol-5-il)amino]-2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il]metil]cikloheksankarboksilna kiselina

Country Status (37)

Country Link
US (2) US8299060B2 (me)
EP (1) EP2448933B1 (me)
JP (1) JP5689875B2 (me)
KR (1) KR101404893B1 (me)
CN (1) CN102639528B (me)
AR (1) AR077208A1 (me)
AU (1) AU2010266537B2 (me)
BR (1) BRPI1011931A2 (me)
CA (1) CA2764425C (me)
CL (1) CL2011003263A1 (me)
CO (1) CO6480934A2 (me)
CR (1) CR20110669A (me)
DK (1) DK2448933T3 (me)
DO (1) DOP2011000405A (me)
EA (1) EA020600B1 (me)
EC (1) ECSP11011551A (me)
ES (1) ES2435293T3 (me)
GT (1) GT201100321A (me)
HR (1) HRP20130950T1 (me)
IL (1) IL216655A (me)
JO (1) JO2867B1 (me)
MA (1) MA33385B1 (me)
ME (1) ME01606B (me)
MX (1) MX2011014024A (me)
MY (1) MY157121A (me)
NZ (1) NZ596820A (me)
PE (1) PE20120538A1 (me)
PL (1) PL2448933T3 (me)
PT (1) PT2448933E (me)
RS (1) RS52988B (me)
SG (1) SG177413A1 (me)
SI (1) SI2448933T1 (me)
TN (1) TN2011000638A1 (me)
TW (1) TWI450896B (me)
UA (1) UA109409C2 (me)
WO (1) WO2011002696A1 (me)
ZA (1) ZA201108707B (me)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012093A1 (en) * 2004-06-24 2006-02-02 Eli Lilly And Company Compounds and methods for treating dyslipidemia
AR077208A1 (es) * 2009-06-30 2011-08-10 Lilly Co Eli Derivados del acido trans-4-[[(5s)-5-[[[3,5-bis(trifluorometil) fenil] metil] (2-metil-2h-tetrazol-5-il) amino) -2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il) metil)-ciclohexancarboxilico y sus formas cristalinas, composiciones farmaceuticas que los comprenden, su uso para preparar un medicam
TWI627167B (zh) 2011-07-08 2018-06-21 諾華公司 用於高三酸甘油酯個體治療動脈粥狀硬化之方法
WO2014012401A1 (zh) * 2012-07-16 2014-01-23 上海恒瑞医药有限公司 苯并七元杂环类衍生物、其制备方法及其在医药上的应用
CA2891710C (en) 2013-01-31 2017-08-01 Chong Kun Dang Pharmaceutical Corp. Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as cetp inhibitors
CN105017085B (zh) * 2014-04-28 2018-06-29 中国科学院上海药物研究所 一类kcnq钾通道激动剂、其制备方法和用途
EP3795695A1 (en) 2014-07-30 2021-03-24 F. Hoffmann-La Roche AG Genetic markers for predicting responsiveness to therapy
TWI691331B (zh) 2014-09-26 2020-04-21 日商興和股份有限公司 脂質異常症治療劑
CN108456213B (zh) * 2017-02-22 2021-01-15 浙江九洲药业股份有限公司 一种3-氟-4-羟基环己烷羧酸酯的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4948639B1 (me) 1970-12-15 1974-12-23
US6197786B1 (en) 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
US6147089A (en) 1998-09-17 2000-11-14 Pfizer Inc. Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
GT199900147A (es) 1998-09-17 1999-09-06 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
CO5271716A1 (es) 1999-11-30 2003-04-30 Pfizer Prod Inc Cristales de 4- carboxamino 1,2,3,4-tetrahidroquinolina 2- sustituida
HN2000000203A (es) 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
ES2259080T3 (es) 2001-04-30 2006-09-16 Pfizer Products Inc. Procedimientos e intermedios para preparar inhibidores cetp.
NZ532494A (en) 2002-08-30 2006-03-31 Japan Tobacco Inc Dibenzylamine compound and medicinal use thereof
PL376156A1 (en) 2002-10-04 2005-12-27 Millennium Pharmaceuticals, Inc. Pgd2 receptor antagonists for the treatment of inflammatory diseases
WO2004078730A2 (en) 2003-03-04 2004-09-16 Takasago International Corporation Method for producing optically active amines
US20040204450A1 (en) 2003-03-28 2004-10-14 Pfizer Inc Quinoline and quinoxaline compounds
US7749992B2 (en) * 2003-10-08 2010-07-06 Eli Lilly And Company Compounds and methods for treating dislipidemia
DE602005008416D1 (de) 2004-03-26 2008-09-04 Lilly Co Eli Verbindungen zur behandlung von dyslipidemie
CN1972927A (zh) * 2004-06-24 2007-05-30 伊莱利利公司 用于治疗血脂障碍的化合物和方法
WO2006012093A1 (en) * 2004-06-24 2006-02-02 Eli Lilly And Company Compounds and methods for treating dyslipidemia
US7700774B2 (en) 2004-12-20 2010-04-20 Dr. Reddy's Laboratories Ltd. Heterocyclic compounds and their pharmaceutical compositions
AR077208A1 (es) * 2009-06-30 2011-08-10 Lilly Co Eli Derivados del acido trans-4-[[(5s)-5-[[[3,5-bis(trifluorometil) fenil] metil] (2-metil-2h-tetrazol-5-il) amino) -2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il) metil)-ciclohexancarboxilico y sus formas cristalinas, composiciones farmaceuticas que los comprenden, su uso para preparar un medicam

Also Published As

Publication number Publication date
AU2010266537B2 (en) 2013-04-18
EP2448933B1 (en) 2013-08-28
RS52988B (en) 2014-02-28
UA109409C2 (ru) 2015-08-25
EP2448933A1 (en) 2012-05-09
CL2011003263A1 (es) 2012-07-27
EA020600B1 (ru) 2014-12-30
AU2010266537A1 (en) 2012-02-02
WO2011002696A1 (en) 2011-01-06
CN102639528B (zh) 2014-07-16
GT201100321A (es) 2012-11-15
DK2448933T3 (da) 2013-10-07
CA2764425C (en) 2015-01-06
US20120058990A1 (en) 2012-03-08
CO6480934A2 (es) 2012-07-16
ES2435293T3 (es) 2013-12-18
NZ596820A (en) 2013-07-26
DOP2011000405A (es) 2012-01-15
AR077208A1 (es) 2011-08-10
KR20120027426A (ko) 2012-03-21
US8329688B2 (en) 2012-12-11
MY157121A (en) 2016-05-13
PT2448933E (pt) 2013-10-29
MA33385B1 (fr) 2012-06-01
ECSP11011551A (es) 2012-01-31
JP5689875B2 (ja) 2015-03-25
CR20110669A (es) 2012-03-16
TWI450896B (zh) 2014-09-01
BRPI1011931A2 (pt) 2016-04-19
TW201113275A (en) 2011-04-16
SI2448933T1 (sl) 2013-11-29
US8299060B2 (en) 2012-10-30
SG177413A1 (en) 2012-02-28
JO2867B1 (en) 2015-03-15
TN2011000638A1 (en) 2013-05-24
CA2764425A1 (en) 2011-01-06
JP2012532106A (ja) 2012-12-13
ZA201108707B (en) 2013-05-29
PE20120538A1 (es) 2012-05-09
EA201270099A1 (ru) 2012-05-30
US20100331309A1 (en) 2010-12-30
HRP20130950T1 (hr) 2013-11-22
KR101404893B1 (ko) 2014-06-20
CN102639528A (zh) 2012-08-15
MX2011014024A (es) 2012-04-20
PL2448933T3 (pl) 2014-01-31
IL216655A0 (en) 2012-02-29
IL216655A (en) 2015-02-26

Similar Documents

Publication Publication Date Title
IL216655A (en) Trans - 4 - [[(5 s) –5 - [[[5,3– bis (trifluoromethyl) phenyl] methyl] (2 – methyl – 2 h– tetrazol-5-yl) amino] –5,4,3,2 -Tetrahydro-9,7-Dimethyl-1 h-1-Benzapine-1-yl] methyl] -Cyclohexanecarboxylic acid
HK1223929A1 (zh) -氨基- -二氫- -二氮雜萘 -二酮鈉鹽的晶型
IL200548A0 (en) Ppar active compounds
IL200543A0 (en) Ppar active compounds
SI2097381T1 (sl) 4-(4-((4-kloro-3-(trifluorometil)fenil))karbamoil)amino)-3- fluorofenoksi)-n-metilpiridin-2-karbokasamid monohidrat
GB0722472D0 (en) Herbicidal compounds
EP2511269A4 (en) FUSED HETEROCYCLIC COMPOUND HAVING AN AMINO GROUP
IL222365A (en) 2,2 '- ({[3-Butyl-3-Ethyl-7- (Methyloxy) -1,1-Dioxide-5-Phenyl-5,4,3,2-Tetra Hydro-1, 4-Benzothiazepine-8 Methyl (imino) acetic acid
ZA201005097B (en) Herbicidal compounds
GB0800856D0 (en) Herbicidal compounds
GB0805318D0 (en) Herbicidal compounds
IL193468A0 (en) Herbicidal isoxazoline compounds
PL2520575T3 (pl) Związek 1,3,4-oksadiazolo-2-karboksyamidowy
EP2117490A4 (en) DISPOSABLE TRANSPORTER
EP2196459A4 (en) 5-GROUND HETEROCYCLIC COMPOUND
ZA201004768B (en) Tosylate salt of trans-n-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl0-phenyl]cyclobut anecarboxamide
IL200048A (en) Solid forms of microbiocide
TWI346662B (en) Oxadiazole compounds
IL213328A0 (en) Regeneration of 2,2'-cyclopropylidene-bis (oxazolines)
CY1114514T1 (el) Τrανs-4-[[(5s)-5-[[[3,5-δις(τριφθορομεθυλ)φαινυλ]μεθυλ](2-μεθυλ-2η-τετραζολ-5-υλ)αμινο]-2,3,4,5-τετραϋδρο-7,9-διμεθυλ-1η-1-βενζαζεπιν-1 -υλ]μεθυλ]-κυκλοεξανο-καρβοξυλικο οξυ
GB0906512D0 (en) Bio amino acid fabric & Bio amino acid compound
GB0710133D0 (en) Preparation of fish for consumption
AU313080S (en) Rake head